Literature DB >> 7870668

The influence of net water absorption on the permeability of antipyrine and levodopa in the human jejunum.

D Nilsson1, U Fagerholm, H Lennernäs.   

Abstract

Food ingestion can influence the absorption of levodopa in the intestine and thereby contribute to fluctuations of motor functions in Parkinson patients. Obstruction of the active transport of levodopa by amino acids can be one factor. Paracellular drug absorption, a route proposed to be influenced by net transport of water across the intestinal epithelium, might occur for a small and hydrophilic drug such as levodopa. In the present study we studied how luminal L-leucine (60 mmol/L), alone or combined with hypotonicity, might stimulate net water absorption, and levodopa uptake in the human small intestine, since this possibly can contribute to the variable intestinal absorption of levodopa. The Loc-I-Gut perfusion technique was used in 10 healthy volunteers to study the effects of induced net fluid absorption on the small intestinal absorption of levodopa (2.5 mmol/L). An induced net fluid absorption was observed only when L-leucine was combined with a hypoosmolar perfusion solution. However, this did not enhance the intestinal permeability of levodopa. In conclusion, we suggest that the variability in the absorption of levodopa in Parkinson's disease cannot be explained by differences in transmucosal water flux in the human small intestine.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7870668     DOI: 10.1023/a:1018941200575

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  Pharmacokinetics and effects of levodopa in advanced Parkinson's disease.

Authors:  E Bredberg; J Tedroff; S M Aquilonius; L Paalzow
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals.

Authors:  V S Chadwick; S F Phillips; A F Hofmann
Journal:  Gastroenterology       Date:  1977-08       Impact factor: 22.682

3.  Inhibition of L-[18F]fluorodopa uptake into human brain by amino acids demonstrated by positron emission tomography.

Authors:  K L Leenders; W H Poewe; A J Palmer; D P Brenton; R S Frackowiak
Journal:  Ann Neurol       Date:  1986-08       Impact factor: 10.422

4.  The effects of oral protein on the absorption of intraduodenal levodopa and motor performance.

Authors:  J P Frankel; P A Kempster; M Bovingdon; R Webster; A J Lees; G M Stern
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-09       Impact factor: 10.154

5.  The contribution of solvent drag to the intestinal absorption of the basic drugs amidopyrine and antipyrine from the jejunum of the rat.

Authors:  H Ochsenfahrt; D Winne
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Solvent drag in jejunal absorption of salicylic acid and antipyrine obtained by in situ single-pass perfusion method in rat.

Authors:  T Hirasawa; T Muraoka; A Karino; M Hayashi; S Awazu
Journal:  J Pharmacobiodyn       Date:  1984-04

7.  Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enalaprilat.

Authors:  H Lennernäs; O Ahrenstedt; A L Ungell
Journal:  Br J Clin Pharmacol       Date:  1994-06       Impact factor: 4.335

8.  Generality in effects of transmucosal fluid movement and glucose on drug absorption from the rat small intestine.

Authors:  S Kitazawa; H Ito; I Johno; T Takahashi; H Takenaka
Journal:  Chem Pharm Bull (Tokyo)       Date:  1978-03       Impact factor: 1.645

9.  Nutrient-induced changes in the permeability of the rat jejunal mucosa.

Authors:  N A See; P Bass
Journal:  J Pharm Sci       Date:  1993-07       Impact factor: 3.534

10.  Meal-induced jejunal absorption requires intact neural pathways.

Authors:  G J Anthone; B H Wang; M J Zinner; M S Orandle; C J Yeo
Journal:  Am J Surg       Date:  1992-01       Impact factor: 2.565

View more
  6 in total

Review 1.  Why is it challenging to predict intestinal drug absorption and oral bioavailability in human using rat model.

Authors:  Xianhua Cao; Seth T Gibbs; Lanyan Fang; Heather A Miller; Christopher P Landowski; Ho-Chul Shin; Hans Lennernas; Yanqiang Zhong; Gordon L Amidon; Lawrence X Yu; Duxin Sun
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

2.  The use of BDDCS in classifying the permeability of marketed drugs.

Authors:  Leslie Z Benet; Gordon L Amidon; Dirk M Barends; Hans Lennernäs; James E Polli; Vinod P Shah; Salomon A Stavchansky; Lawrence X Yu
Journal:  Pharm Res       Date:  2008-01-31       Impact factor: 4.200

3.  Comparison between permeability coefficients in rat and human jejunum.

Authors:  U Fagerholm; M Johansson; H Lennernäs
Journal:  Pharm Res       Date:  1996-09       Impact factor: 4.200

4.  Prediction of the oral absorption of low-permeability drugs using small intestine-like 2/4/A1 cell monolayers.

Authors:  Staffan Tavelin; Jan Taipalensuu; Lauri Söderberg; Rick Morrison; Saeho Chong; Per Artursson
Journal:  Pharm Res       Date:  2003-03       Impact factor: 4.200

5.  Increased absorption of digoxin from the human jejunum due to inhibition of intestinal transporter-mediated efflux.

Authors:  Svitlana Igel; Siegfried Drescher; Thomas Mürdter; Ute Hofmann; Georg Heinkele; Heike Tegude; Hartmut Glaeser; Stefanie S Brenner; Andrew A Somogyi; Taher Omari; Christian Schäfer; Michel Eichelbaum; Martin F Fromm
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 6.  Does fluid flow across the intestinal mucosa affect quantitative oral drug absorption? Is it time for a reevaluation?

Authors:  H Lennernäs
Journal:  Pharm Res       Date:  1995-11       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.